Malaria: Burden of Disease, Current Molecular Medicine, vol.6, issue.2, pp.137-140, 2006. ,
DOI : 10.2174/156652406776055131
Antibodies to the N-Terminal Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Associated with Protection against Clinical Malaria, Infection and Immunity, vol.72, issue.11, pp.6492-6502, 2004. ,
DOI : 10.1128/IAI.72.11.6492-6502.2004
Merozoite Surface Protein 1 and to the Merozoite Extract and Their Relationship with In Vitro Inhibitory Antibodies and Protection against Clinical Malaria in a Senegalese Village, The Journal of Infectious Diseases, vol.191, issue.2, pp.264-271, 2005. ,
DOI : 10.1086/426398
URL : https://hal.archives-ouvertes.fr/pasteur-00494323
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya, Vaccine, vol.24, issue.19, pp.4233-4246, 2006. ,
DOI : 10.1016/j.vaccine.2005.06.030
Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein, Infection and Immunity, vol.72, issue.1, pp.247-252, 2004. ,
DOI : 10.1128/IAI.72.1.247-252.2004
Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites, Am J Trop Med Hyg, vol.60, pp.135-141, 1999. ,
Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species, Nature Medicine, vol.65, issue.1, pp.91-95, 2000. ,
DOI : 10.1073/pnas.93.14.7289
Immunity against Plasmodium falciparum blood stage: the challenge of immuno-epidemiology studies for vaccine design, Update in Tropical Immunology. Trivandum-695 023Kerala, India: Research Signpost, pp.157-172, 2005. ,
Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies, Journal of Clinical Microbiology, vol.44, issue.5, pp.1665-1673, 2006. ,
DOI : 10.1128/JCM.44.5.1665-1673.2006
Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens, Am J Trop Med Hyg, vol.75, pp.437-442, 2006. ,
Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-Stage Plasmodium falciparum, Clinical and Vaccine Immunology, vol.15, issue.9, pp.1345-1355, 2008. ,
DOI : 10.1128/CVI.00172-08
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages, Journal of Experimental Medicine, vol.182, issue.2, pp.409-418, 1995. ,
DOI : 10.1084/jem.182.2.409
Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals, Infect Immun, vol.35, pp.874-879, 1982. ,
Phagocytosis of Plasmodium falciparum-Parasitized Erythrocytes by Human Polymorphonuclear Leukocytes, The Journal of Parasitology, vol.69, issue.1, pp.49-53, 1983. ,
DOI : 10.2307/3281273
Schizonts, merozoites, and phagocytosis in falciparum malaria, Ann Clin Lab Sci, vol.15, pp.465-469, 1985. ,
Inhibition of the in vitro growth of Plasmodium falciparum by human polymorphonuclear neutrophil leucocytes, Clin Exp parasitol, vol.46, pp.106-109, 1981. ,
Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria, Infect Immun, vol.39, pp.1-6, 1983. ,
The Role of Cell-Mediated Immune Responses in Resistance to Malaria, with Special Reference to Oxidant Stress, Annual Review of Immunology, vol.1, issue.1, pp.361-392, 1983. ,
DOI : 10.1146/annurev.iy.01.040183.002045
Malaria, The Journal of Infectious Diseases, vol.179, issue.6, pp.1584-1586, 1999. ,
DOI : 10.1086/314780
Malaria Vaccine: Candidate Antigens, Mechanisms, Constraints and Prospects, Scandinavian Journal of Immunology, vol.56, issue.4, pp.327-343, 2002. ,
DOI : 10.1046/j.1365-3083.2002.01160.x
Immune effector mechanisms in malaria, Parasite Immunology, vol.27, issue.1-2, pp.51-60, 2006. ,
DOI : 10.1016/S0140-6736(02)09784-2
A new approach for analysis of chemiluminescent kinetics of activated phagocytes in blood, Journal of Bioluminescence and Chemiluminescence, vol.1989, issue.2, pp.77-84, 1995. ,
DOI : 10.1002/bio.1170100203
Respiratory burst in human neutrophils, Journal of Immunological Methods, vol.232, issue.1-2, pp.3-14, 1999. ,
DOI : 10.1016/S0022-1759(99)00146-5
Neutrophils: Molecules, Functions and Pathophysiological Aspects, Laboratory Investigation, vol.89, issue.5, pp.617-653, 2000. ,
DOI : 10.1038/42506
Phagocytosis by neutrophils, Microbes and Infection, vol.5, issue.14, pp.1299-1306, 2003. ,
DOI : 10.1016/j.micinf.2003.09.014
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites, Infect Immun, vol.60, pp.3731-3738, 1992. ,
Activation of phagocyte oxidative metabolism by opsonized Plasmodium falciparum merozoites, Acta Tropica, vol.47, issue.2, pp.61-68, 1990. ,
DOI : 10.1016/0001-706X(90)90068-B
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes, Infect Immun, vol.65, pp.3834-3837, 1997. ,
The need for assays predictive of protection in development of malaria bloodstage vaccines, Parasitology Today, vol.13, issue.2, pp.46-47, 1997. ,
DOI : 10.1016/S0169-4758(96)20063-8
Infection and Clinical Malaria Identified in a Senegalese Community after Radical Drug Cure, The Journal of Infectious Diseases, vol.188, issue.12, pp.1940-1950, 2003. ,
DOI : 10.1086/379838
URL : https://hal.archives-ouvertes.fr/pasteur-00566835
Potency assay design for adjuvanted recombinant proteins as malaria vaccines, Vaccine, vol.24, issue.20, pp.4264-4270, 2006. ,
DOI : 10.1016/j.vaccine.2006.01.005
The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal, Am J Trop Med Hyg, vol.51, pp.123-137, 1994. ,
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal, Parassitologia, vol.41, pp.255-259, 1999. ,
Cohorts and biolibraries for studying malaria in tropical areas], Rev Epidemiol Sante Publique, vol.51, pp.175-182, 2003. ,
Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate, Vaccine, vol.24, issue.33-34, pp.5997-6008, 2006. ,
DOI : 10.1016/j.vaccine.2006.04.069
Re-assessment of culture inhibition assays and reinvasion of P. falciparum for the appraisal of immunity of individuals living in an endemic area], Dakar Med, vol.47, pp.5-11, 2002. ,
Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks, 1999. ,
Stimulation of the chemiluminescence of human polymorphonuclear leukocytes in various stages of the intraerythrocyte development of Plasmodium falciparum, C R Seances Soc Biol Fil, vol.182, pp.270-278, 1988. ,
Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum, Infect Immun, vol.51, pp.801-806, 1986. ,
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum, Infect Immun, vol.58, pp.788-793, 1990. ,
Blood and bone marrow changes in malaria, Best Practice & Research Clinical Haematology, vol.13, issue.2, pp.277-299, 2000. ,
DOI : 10.1053/beha.1999.0072
Mixed-species malaria infections in humans, Trends in Parasitology, vol.20, issue.5, pp.233-240, 2004. ,
DOI : 10.1016/j.pt.2004.03.006
Malarial anaemia in African children associated with high oxygen-radical production, Lancet, vol.355, pp.40-41, 2000. ,
Effector cells involved in nonspecific and antibodydependent mechanisms directed against Plasmodium falciparum blood stages in vitro, Infect Immun, vol.57, pp.2043-2049, 1989. ,
Association of the IgG response to Plasmodium falciparum merozoite protein (Cterminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region, Am J Trop Med Hyg, vol.66, pp.461-466, 2002. ,
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria, Parasite Immunology, vol.66, issue.6, pp.307-312, 2003. ,
DOI : 10.1016/S1471-4906(02)00012-1
Evidence for a neutrophil-mediated protective response in malaria, Parasite Immunology, vol.43, issue.1, pp.47-58, 1988. ,
DOI : 10.1016/S0140-6736(71)91004-X
Opsonization and Phagocytosis of Plasmodium falciparum Merozoites Measured by Flow Cytometry, Clinical and Vaccine Immunology, vol.7, issue.1, pp.9-13, 2000. ,
DOI : 10.1128/CDLI.7.1.9-13.2000